Health Care Reform

If we can play at being race care drivers and airplane pilots, why not take a turn as the nervous stewards of dwindling pots of premium dollars?

Matthew Fiedler wants policymakers to pay more attention to the drug manufacturers.

While rising costs are concerning, there’s good news -- 84% of employers’ health plan spend is tied to areas can be managed strategically to reduce costs without compromising care.

Medicare Part D spending for 10 selected diabetes drugs surged from $7.7 billion in 2019 to $35.8 billion in 2023, an audit by the U.S. Department of Health and Human Services Office of Inspector General found.

One Republican and three Democrats crossed party lines.

Medicare market disruption hurt the web broker's Q4 benefit plan sales, but the CEO is still optimistic about ICHRAs.